Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VisionCare's implantable telescope enters US trial:

This article was originally published in Clinica

Executive Summary

VisionCare Ophthalmic Technologies has begun a US clinical trial of its Implantable Miniturized Telescope (IMT) for treating dry or scar stage age-related macular degeneration (AMD). The device is implanted in one eye, which provides central vision, while the non-operated eye provides peripheral vision. Implantation of the device involves a 30-45 minute out-patient procedure under local anaesthesia. There are currently no treatments available to correct vision loss in patients with AMD, claims the Saratoga, California company. The device was CE-marked for sale in Europe last year but has not yet been launched.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074972

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel